Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: January 01, 2020
All Medicare Advantage (MA) organizations are required to have a quality improvement (QI) program as described in the federal regulations at 42 CFR 422.152, “Quality improvement program”. The requirements for the Prescription Drug Plan (PDP) Quality Assurance program are described at 42 CFR 423.153(c).
The primary goal of the MA organization’s QI program is to effect sustained improvement in patient health outcomes. As provided under 42 CFR 422.152(c), an MA organization’s QI program must include a chronic care improvement program (CCIP). The QI program must also include a health information system to collect, analyze, and report Medicare Parts C & D quality performance data, including Healthcare Effectiveness Data and Information Set (HEDIS®), Health Outcomes Survey (HOS), and Consumer Assessment of Healthcare Providers and Systems (CAHPS®) data.
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.